Unique ID issued by UMIN | UMIN000023442 |
---|---|
Receipt number | R000026968 |
Scientific Title | Phase II trial of Transcatheter arterial micro-embolization for refractory chronic knee pain: Multicenter Study (PATRICK study) |
Date of disclosure of the study information | 2016/08/03 |
Last modified on | 2018/05/08 10:19:23 |
Phase II trial of Transcatheter arterial micro-embolization for refractory chronic knee pain: Multicenter Study (PATRICK study)
knee TAME: JMIS-1602 (PATRICK study)
Phase II trial of Transcatheter arterial micro-embolization for refractory chronic knee pain: Multicenter Study (PATRICK study)
knee TAME: JMIS-1602 (PATRICK study)
Japan |
chronic knee pain refractory to non-surgical management due to mild osteoarthritis or after artificial joint replacement
Orthopedics | Radiology |
Others
NO
Phase II trial of Transcatheter arterial micro-embolization for refractory chronic knee pain: Multicenter Study (PATRICK study)
Efficacy
Phase II
Numerical Rating Scale (NRS) in 6 months after procedure
Japanese knee osteoarthritis measure(JCOM) score in 6 months after procedure
Quality of Life(QOL) in 6 months after procedure
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Transcatheter arterial micro embolization: TAME
20 | years-old | <= |
85 | years-old | > |
Male and Female
1.Previous conservative therapies applied for at least 3 months and persistent moderate-to-severe knee pain (NRS>=5).
2.Chronic knee pain with mild osteoarthritis or after artificial joint replacement
3.Patients with no severe knee osteoarthritis (Kellgren-Lawrence grading system 0-2)
4.Patients with maintain major organ (bone marrow, heart, liver, lung, kidney) function.
5.Patients with possibility of going to hospital and follow up for 6 months.
6.Provided written informed consent to undergo the procedure.
1.Surgical candidate
2.Patients with severe infection, rheumatoid arthritis, or mental disorder
3.Patients with uncontrollable diabetic mellitus
4.Pain due to spine pathology
5.Patients with osteonecrosis with magnetic resonance imaging (MRI)
6.Patients without possibility of going to hospital and follow up for 6 months.
7.Patient who was decided not to be appropriate for this trial by physician
50
1st name | |
Middle name | |
Last name | Taku Yasumoto |
Miyakojima IGRT clinic
Department of Interventional Radiology
1-16-22 Miyakojima Hondori, Miyakojima-ku, Osaka, 534-0021, JAPAN
06-6923-3501
yasumoto@solid.ocn.ne.jp
1st name | |
Middle name | |
Last name | Taku Yasumoto |
Miyakojima IGRT clinic
Department of Interventional Radiology
1-16-22 Miyakojima Hondori, Miyakojima-ku, Osaka, 534-0021, JAPAN
06-6923-3501
yasumoto@solid.ocn.ne.jp
Miyakojima IGRT clinic
None
Self funding
NO
2016 | Year | 08 | Month | 03 | Day |
Unpublished
Completed
2016 | Year | 07 | Month | 08 | Day |
2016 | Year | 08 | Month | 03 | Day |
2016 | Year | 08 | Month | 02 | Day |
2018 | Year | 05 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026968